We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
+4.91%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$4.68B
AUM Growth
-$145M
Cap. Flow
-$113M
Cap. Flow %
-2.41%
Top 10 Hldgs %
14.09%
Holding
1,671
New
224
Increased
657
Reduced
447
Closed
328

Top Buys

Rank Stock Value
1
MPC icon
Marathon Petroleum
MPC
+$29M
2
NU icon
Nu Holdings
NU
+$25.8M
3
PG icon
Procter & Gamble
PG
+$23.5M
4
NKE icon
Nike
NKE
+$23.1M
5
GRAB icon
Grab
GRAB
+$22.3M

Top Sells

Rank Stock Value
1
JD icon
JD.com
JD
+$44.7M
2
NTES icon
NetEase
NTES
+$40.5M
3
AMD icon
Advanced Micro Devices
AMD
+$37.8M
4
MELI icon
Mercado Libre
MELI
+$33.9M
5
PDD icon
Pinduoduo
PDD
+$33.8M

Sector Composition

Rank Sector Weight
1 Technology 30.82%
2 Consumer Discretionary 19.78%
3 Communication Services 10.14%
4 Financials 6.66%
5 Industrials 6.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RYTM icon
1526
Rhythm Pharmaceuticals
RYTM
$7.96B
– –
-1,145
Closed -$14K
SAGE
1527
DELISTED
Sage Therapeutics
SAGE
– –
-1,345
Closed -$59K
SAH icon
1528
Sonic Automotive
SAH
$2.61B
– –
-1,602
Closed -$84K
SGMO
1529
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
– –
-3,325
Closed -$29K
SHYG icon
1530
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.6B
– –
-490
Closed -$22K
SIG icon
1531
Signet Jewelers
SIG
$3.76B
– –
-7,452
Closed -$588K
SIGA icon
1532
SIGA Technologies
SIGA
$219M
– –
-1,715
Closed -$12K
SKT icon
1533
Tanger
SKT
$4.52B
– –
-5,029
Closed -$81K
SMMT icon
1534
Summit Therapeutics
SMMT
$11.1B
– –
-2,225
Closed -$11K
SNDX icon
1535
Syndax Pharmaceuticals
SNDX
$1.82B
– –
-1,115
Closed -$21K
SOL
1536
DELISTED
Emeren Group
SOL
– –
-1,762
Closed -$11K
SPRO icon
1537
Spero Therapeutics
SPRO
$73M
– –
-730
Closed -$13K
SRRK icon
1538
Scholar Rock
SRRK
$6.44B
– –
-790
Closed -$26K
STE icon
1539
Steris
STE
$23.1B
– –
-2,745
Closed -$560K
STOK icon
1540
Stoke Therapeutics
STOK
$2.11B
– –
-840
Closed -$21K
STRO icon
1541
Sutro Biopharma
STRO
$421M
– –
-106
Closed -$19K
SUPN icon
1542
Supernus Pharmaceuticals
SUPN
$2.77B
– –
-1,215
Closed -$32K
SWTX
1543
DELISTED
SpringWorks Therapeutics
SWTX
– –
-1,130
Closed -$71K
SYRE icon
1544
Spyre Therapeutics
SYRE
$9.25B
– –
-45
Closed -$8K
TASK icon
1545
TaskUs
TASK
$669M
– –
-132,067
Closed -$8.77M
TBPH icon
1546
Theravance Biopharma
TBPH
$877M
– –
-1,685
Closed -$12K
TCRT icon
1547
Alaunos Therapeutics
TCRT
$4.86M
– –
-33
Closed -$8K
TECH icon
1548
Bio-Techne
TECH
$11.3B
– –
-4,500
Closed -$545K
TLH icon
1549
iShares 10-20 Year Treasury Bond ETF
TLH
$10.9B
– –
-984
Closed -$144K
TOUR
1550
Tuniu
TOUR
$55.6M
– –
-4,120
Closed -$62K
60 61
62
63 64

Similar funds

GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $8.58B AUM 23.43% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Penserra Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Penserra Capital Management held 1,671 positions worth $4.68B, down 3% from $4.82B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Penserra Capital Management's Q4 2021 filing shows 224 new, 657 increased, 447 reduced and 328 closed positions. Its largest new stake was Marathon Petroleum: 451,379 shares worth $28.9M. The largest sale was JD.com, an estimated $44.7M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Penserra Capital Management's largest Q4 2021 buy was Marathon Petroleum: 451,379 shares worth $28.9M.
  • Penserra Capital Management added most to Procter & Gamble in Q4 2021, an estimated $23.5M increase.
  • Penserra Capital Management's biggest Q4 2021 reduction was JD.com, cutting an estimated $44.7M.
  • Penserra Capital Management fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $32.7M.
  • Penserra Capital Management's ten largest holdings make up 14% of its $4.68B portfolio in Q4 2021.
  • Penserra Capital Management opened 224 new positions and closed 328 in Q4 2021.
  • Penserra Capital Management's portfolio value fell 3% quarter-over-quarter to $4.68B.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.